297 related articles for article (PubMed ID: 37207534)
1. Highlights on U.S. FDA-approved fluorinated drugs over the past five years (2018-2022).
Ali S; Zhou J
Eur J Med Chem; 2023 Aug; 256():115476. PubMed ID: 37207534
[TBL] [Abstract][Full Text] [Related]
2. Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023.
Ali S; Bolinger AA; Zhou J
Curr Top Med Chem; 2024; 24(10):843-849. PubMed ID: 38445700
[TBL] [Abstract][Full Text] [Related]
3. New drug approvals for 2021: Synthesis and clinical applications.
Yuan S; Wang DS; Liu H; Zhang SN; Yang WG; Lv M; Zhou YX; Zhang SY; Song J; Liu HM
Eur J Med Chem; 2023 Jan; 245(Pt 1):114898. PubMed ID: 36370552
[TBL] [Abstract][Full Text] [Related]
4. The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules.
de la Torre BG; Albericio F
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770706
[TBL] [Abstract][Full Text] [Related]
5. Data-mining for sulfur and fluorine: an evaluation of pharmaceuticals to reveal opportunities for drug design and discovery.
Ilardi EA; Vitaku E; Njardarson JT
J Med Chem; 2014 Apr; 57(7):2832-42. PubMed ID: 24102067
[TBL] [Abstract][Full Text] [Related]
6. US-FDA Approved Drugs in 2020 and 2021: A Review.
Passi I; Salwan S; Kumar B
Mini Rev Med Chem; 2023; 23(12):1273-1297. PubMed ID: 36503454
[TBL] [Abstract][Full Text] [Related]
7. The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals from the Perspective of Molecules.
de la Torre BG; Albericio F
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338330
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and clinical application of new drugs approved by FDA in 2023.
Wang YT; Yang PC; Zhang YF; Sun JF
Eur J Med Chem; 2024 Feb; 265():116124. PubMed ID: 38183778
[TBL] [Abstract][Full Text] [Related]
9. The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules.
G de la Torre B; Albericio F
Molecules; 2019 Feb; 24(4):. PubMed ID: 30813407
[TBL] [Abstract][Full Text] [Related]
10. U.S. FDA Approved Drugs from 2015-June 2020: A Perspective.
Bhutani P; Joshi G; Raja N; Bachhav N; Rajanna PK; Bhutani H; Paul AT; Kumar R
J Med Chem; 2021 Mar; 64(5):2339-2381. PubMed ID: 33617716
[TBL] [Abstract][Full Text] [Related]
11. Cancer drugs approved for use in children: Impact of legislative initiatives and future opportunities.
Barone A; Casey D; McKee AE; Reaman G
Pediatr Blood Cancer; 2019 Aug; 66(8):e27809. PubMed ID: 31144772
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017.
Zhang AD; Puthumana J; Downing NS; Shah ND; Krumholz HM; Ross JS
JAMA Netw Open; 2020 Apr; 3(4):e203284. PubMed ID: 32315070
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in pharmaceutical salts: FDA approvals from 2015 to 2019.
Bharate SS
Drug Discov Today; 2021 Feb; 26(2):384-398. PubMed ID: 33221522
[TBL] [Abstract][Full Text] [Related]
14. 2014 in review: FDA approval of new drugs.
Kinch MS
Drug Discov Today; 2017 Apr; 22(4):620-624. PubMed ID: 26100738
[TBL] [Abstract][Full Text] [Related]
15. FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022.
Rizzo C; Amata S; Pibiri I; Pace A; Buscemi S; Palumbo Piccionello A
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175436
[TBL] [Abstract][Full Text] [Related]
16. Approval of Cancer Drugs With Uncertain Therapeutic Value: A Comparison of Regulatory Decisions in Europe and the United States.
Salcher-Konrad M; Naci H; Davis C
Milbank Q; 2020 Dec; 98(4):1219-1256. PubMed ID: 33021339
[TBL] [Abstract][Full Text] [Related]
17. Development times, clinical testing, postmarket follow-up, and safety risks for the new drugs approved by the US food and drug administration: the class of 2008.
Moore TJ; Furberg CD
JAMA Intern Med; 2014 Jan; 174(1):90-5. PubMed ID: 24166236
[TBL] [Abstract][Full Text] [Related]
18. Oncology drug development and approval of systemic anticancer therapy by the U.S. Food and Drug Administration.
Martell RE; Sermer D; Getz K; Kaitin KI
Oncologist; 2013; 18(1):104-11. PubMed ID: 23263289
[TBL] [Abstract][Full Text] [Related]
19. New FDA oncology small molecule drugs approvals in 2020: Mechanism of action and clinical applications.
Cristina Mendonça Nogueira T; Vinicius Nora de Souza M
Bioorg Med Chem; 2021 Sep; 46():116340. PubMed ID: 34416511
[TBL] [Abstract][Full Text] [Related]
20. FDA Approval and Regulation of Pharmaceuticals, 1983-2018.
Darrow JJ; Avorn J; Kesselheim AS
JAMA; 2020 Jan; 323(2):164-176. PubMed ID: 31935033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
